Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: COCH) is a medical device company focused on hearing health, best known for developing the Acclaim Cochlear Implant, a fully implanted cochlear implant system designed to provide hearing restoration without external wearable components. The company completed its business combination with Anzu Special Acquisition Corp I — sponsored by Anzu Partners LLC — in 2023, following the SPAC's initial public offering in 2021. The August 2026 8-K filing, accession number 0001213900-26-087221, represents a post-merger disclosure by the combined entity, which operates in the medical technology and hearing device sector. For complete filing history, sponsor economics, and real-time monitoring on Envoy Medical and hundreds of other SPAC transactions, sign up for full access at SpacDesk.